KALA BIO, Inc.

NasdaqCM:KALA Stock Report

Market Cap: US$7.8m

KALA BIO Management

Management criteria checks 1/4

We currently do not have sufficient information about the CEO.

Key information

Avi Minkowitz

Chief executive officer

n/a

Total compensation

CEO salary percentagen/a
CEO tenureless than a year
CEO ownershipn/a
Management average tenure4.7yrs
Board average tenureless than a year

Recent management updates

Recent updates

Kala Pharmaceuticals to execute reverse stock split

Oct 20

Kala Pharmaceuticals Q2 2022 Earnings Preview

Aug 10

CEO

Avi Minkowitz

less than a year
Tenure

Mr. Avi Minkowitz is CEO & CFO at KALA BIO, Inc. from February 2, 2026. He is Director of KALA BIO, Inc. from February 2026. Mr. Minkowitz serves as Director at International Star, Inc. since October 20, 2...

Leadership Team

NamePositionTenureCompensationOwnership
R. Brazzell
Head of R&D and Chief Medical Officer13.1yrsUS$920.69k0.045%
$ 3.5k
Todd Bazemore
Principal Executive Officer & Directorless than a yearUS$949.55k0.051%
$ 4.0k
Avi Minkowitz
CEO, CFO & Directorless than a yearno datano data
Justin Hanes
Founder & Chair of the Scientific Advisory Boardno datano datano data
Jill Steier
Executive Director of Investor Relations & Corporate Communications4.7yrsno datano data
Vincent Kosewski
Senior VP of Manufacturing & Supply Chain Management8.7yrsno datano data
Darius Kharabi
Chief Business Officer4.3yrsno data0.046%
$ 3.5k
Francis Mah
Chief Medical Advisor3yrsno datano data
Mary Reumuth
Treasurer & Secretary12.1yrsno data0%
$ 0
Josiah Craver
Senior VP & Corporate Controller3.9yrsno datano data
Carl Rennie
Executive Director of Account Management7.8yrsno datano data
Patrick Bedell
Executive Director of Trade & Alternate Channels7.8yrsno datano data
4.7yrs
Average Tenure
55yo
Average Age

Experienced Management: KALA's management team is considered experienced (4.7 years average tenure).

Board Members

NamePositionTenureCompensationOwnership
Todd Bazemore
Principal Executive Officer & Directorless than a yearUS$949.55k0.051%
$ 4.0k
Avi Minkowitz
CEO, CFO & Directorless than a yearno datano data
Justin Hanes
Founder & Chair of the Scientific Advisory Boardno datano datano data
Peter Hutt
Member of Scientific Advisory Boardno datano datano data
Ronald Krall
Member of Scientific Advisory Boardno datano datano data
Bennett Shapiro
Member of Scientific Advisory Boardno datano datano data
Colin Gardner
Member of Scientific Advisory Boardno datano datano data
Mark Iwicki
Director10.9yrsUS$1.49m0%
$ 0
Howard Rosen
Independent Director & Member of Advisory Board12.2yrsUS$99.74k0.00093%
$ 72.2
Yonatan Colman
Directorless than a yearno datano data
Chaim Berger
Directorless than a yearno datano data
Brendan Purdy
Directorless than a yearno datano data
0.08yrs
Average Tenure
63yo
Average Age

Experienced Board: KALA's board of directors are not considered experienced ( 0.1 years average tenure), which suggests a new board.

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2026/03/06 05:01
End of Day Share Price 2026/03/06 00:00
Earnings2025/09/30
Annual Earnings2024/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

KALA BIO, Inc. is covered by 7 analysts. 1 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Tazeen AhmadBofA Global Research
Biren AminJefferies LLC
Christopher NeyorJ.P. Morgan